Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JFL Life Sciences's change in inventory for the quarter that ended in Mar. 2026 was ₹-113 Mil. It means JFL Life Sciences's inventory
increased by ₹113 Mil
from Mar. 2025 to Mar. 2026 .
JFL Life Sciences's change in inventory for the fiscal year that ended in Mar. 2026 was ₹-113 Mil. It means JFL Life Sciences's inventory
increased by ₹113 Mil
from Mar. 2025 to Mar. 2026 .
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
JFL Life Sciences's Days Inventory for the quarter that ended in Mar. 2026 was 45.86.
Inventory Turnover measures how fast the company turns over its inventory within a year.
JFL Life Sciences's Inventory Turnover for the quarter that ended in Mar. 2026 was 3.98.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
JFL Life Sciences's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.22.
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
JFL Life Sciences's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JFL Life Sciences Change In Inventory Related Terms
JFL Life Sciences Change In Inventory Historical Data
* Premium members only.
The historical data trend for JFL Life Sciences's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-113 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Inventory of ₹-113 Mil mean?
JFL Life Sciences (NSE:JFLLIFE) has a Change In Inventory of ₹-113 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for JFL Life Sciences and its competitors.
Is JFL Life Sciences' Change In Inventory too high?
JFL Life Sciences' current Change In Inventory is ₹-113 Mil. Overall, JFL Life Sciences has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JFL Life Sciences' Change In Inventory compare to ZTS?
JFL Life Sciences' Change In Inventory of ₹-113 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for JFL Life Sciences and its competitors. JFL Life Sciences's current Change In Inventory is ₹-113 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JFL Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, JFL Life Sciences (NSE:JFLLIFE) is currently considered Possible Value Trap. The stock's GF Value™ is ₹42.73, compared to a current price of ₹9.85 — trading 76.9% below its estimated fair value. The current Change In Inventory is ₹-113 Mil. JFL Life Sciences' overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For JFL Life Sciences (NSE:JFLLIFE), the current Change In Inventory is ₹-113 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JFL Life Sciences (NSE:JFLLIFE) Overvalued in 2026?
Based on GuruFocus' analysis, JFL Life Sciences stock appears to be undervalued.
The current stock price of ₹9.85 is trading 76.9% below its estimated GF Value™ of ₹42.73.
GuruFocus considers JFL Life Sciences to be Possible Value Trap.
Key valuation signals for NSE:JFLLIFE:
Change In Inventory: ₹-113 Mil
GF Value™: ₹42.73 vs. price of ₹9.85 (76.9% below fair value)
No single metric tells the full story. See the NSE:JFLLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.
79GF Score
Get the complete analysis for NSE:JFLLIFE
Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:JFLLIFE has been successfully added to your 
